Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who
have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 …

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and
identification of human SARS-CoV-2 seroconverters. This assay does not require the …

It is concerning that emerging variants of SARS-CoV-2 can evade neutralising antibodies
induced by previous infection or vaccination through mutations in the spike protein, including …

Growing knowledge about the cytokine network response has led to a better comprehension
of mechanisms of pathologies and to the development of new treatments with biological …

In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

New York City (NYC) has emerged as one of the epicenters of the current severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. To identify the early transmission …

COVID-19 mRNA vaccines are highly efficacious in preventing COVID-19 morbidity and
mortality in phase 3 clinical studies as well as in real-world settings. Emerging evidence …

Background Monkeypox virus has recently infected more than 88 000 people, raising concerns
about our preparedness against this emerging viral pathogen. Licensed and approved …

Purpose: The goal of this study is to enhance the efficacy of imipridones, a novel class of
AKT/ERK inhibitors that displayed limited therapeutic efficacy against glioblastoma (GBM). …

In familial and sporadic multiple system atrophy (MSA) patients, deficiency of coenzyme Q
10 (CoQ 10 ) has been associated with mutations in COQ2 , which encodes the second …